Alternative Data News and Insight

Tests used to determine COVID-19 infection have and will continue to play a key role in managing the spread of the virus. As nations race to acquire test kits on a massive scale, a subset of companies in the pharma, biotech, and medical device industries stand to profit from this unprecedented demand. To identify these companies, investors may wish to utilise sources of alternative data that capture the COVID-19 testing market.